Literature DB >> 21293925

Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5.

Yoko Kashiwamura1, Yasuteru Sano, Masaaki Abe, Fumitaka Shimizu, Hiroyo Haruki, Toshihiko Maeda, Motoharu Kawai, Takashi Kanda.   

Abstract

In autoimmune disorders of the peripheral nervous system (PNS), including Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy, breakdown of the blood-nerve barrier (BNB) has been considered to be a key step in the disease process. Although glucocorticoids (GCs) have been shown to effectively restore the blood-brain barrier (BBB) in some inflammatory central nervous system diseases such as multiple sclerosis, their action against the BNB has not yet been examined. To elucidate the role of GCs on the BNB, we established a novel human immortalized endothelial cell lines derived from the BNB. The established cell line termed "DH-BNBs" expresses two important tight junction proteins, claudin-5 and occludin. Using DH-BNBs, we analyzed how GCs affect BNB function. We herein report that GCs up-regulate the expression of claudin-5 and increase the barrier properties of the BNB. This is the first report which indicates how GCs affect the blood-nerve barrier.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293925     DOI: 10.1007/s11064-011-0413-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

Review 1.  Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition.

Authors:  Jean-Michel Vallat; Claudia Sommer; Laurent Magy
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

2.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

3.  Blood-nerve barrier in the frog during wallerian degeneration: are axons necessary for maintenance of barrier function?

Authors:  C H Latker; K C Wadhwani; A Balbo; S I Rapoport
Journal:  J Comp Neurol       Date:  1991-06-22       Impact factor: 3.215

4.  Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis.

Authors:  C Meier; K Roberts; A Steck; C Hess; E Miloni; L Tschopp
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

5.  Isolation and culture of bovine endothelial cells of endoneurial origin.

Authors:  T Kanda; T Iwasaki; M Yamawaki; K Ikeda
Journal:  J Neurosci Res       Date:  1997-09-15       Impact factor: 4.164

6.  Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1.

Authors:  T Kanda; Y Numata; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

7.  Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy.

Authors:  B Lach; P Rippstein; D Atack; D E Afar; A Gregor
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 8.  Glucocorticoid receptor physiology.

Authors:  Marjet D Heitzer; Irene M Wolf; Edwin R Sanchez; Selma F Witchel; Donald B DeFranco
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

9.  Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells.

Authors:  Yasuteru Sano; Fumitaka Shimizu; Hiroto Nakayama; Masaaki Abe; Toshihiko Maeda; Sumio Ohtsuki; Tetsuya Terasaki; Masuo Obinata; Masatsugu Ueda; Ri-ichi Takahashi; Takashi Kanda
Journal:  Cell Struct Funct       Date:  2007-12-05       Impact factor: 2.212

10.  Occludin as a possible determinant of tight junction permeability in endothelial cells.

Authors:  T Hirase; J M Staddon; M Saitou; Y Ando-Akatsuka; M Itoh; M Furuse; K Fujimoto; S Tsukita; L L Rubin
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

View more
  22 in total

1.  High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.

Authors:  Hisham Qosa; Loqman A Mohamed; Sweilem B Al Rihani; Yazan S Batarseh; Quoc-Viet Duong; Jeffrey N Keller; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

2.  Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.

Authors:  Fumitaka Shimizu; Yasuteru Sano; Kazuyuki Saito; Masa-aki Abe; Toshihiko Maeda; Hiroyo Haruki; Takashi Kanda
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

Review 3.  Regulation of paracellular permeability: factors and mechanisms.

Authors:  Yan-Jun Hu; Yi-Dong Wang; Fu-Qing Tan; Wan-Xi Yang
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

4.  Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.

Authors:  Servio H Ramirez; János Haskó; Andrew Skuba; Shongshan Fan; Holly Dykstra; Ryan McCormick; Nancy Reichenbach; Istvan Krizbai; Anu Mahadevan; Ming Zhang; Ronald Tuma; Young-Jin Son; Yuri Persidsky
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

5.  Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO.

Authors:  Jason M Keil; Xuwen Liu; David A Antonetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

6.  Barrier functionality of porcine and bovine brain capillary endothelial cells.

Authors:  Ailar Nakhlband; Yadollah Omidi
Journal:  Bioimpacts       Date:  2011-09-30

Review 7.  Minireview: Steroid/nuclear receptor-regulated dynamics of occluding and anchoring junctions.

Authors:  Gary L Firestone; Bhumika J Kapadia
Journal:  Mol Endocrinol       Date:  2014-09-09

Review 8.  Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

Authors:  Evan B Stubbs
Journal:  Exp Neurol       Date:  2020-06-17       Impact factor: 5.330

9.  Dexamethasone suppresses JMJD3 gene activation via a putative negative glucocorticoid response element and maintains integrity of tight junctions in brain microvascular endothelial cells.

Authors:  Wonho Na; Jee Y Shin; Jee Y Lee; Sangyun Jeong; Won-Sun Kim; Tae Y Yune; Bong-Gun Ju
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-24       Impact factor: 6.200

10.  VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro.

Authors:  Chetan Lakshmana Reddy; Nejla Yosef; Eroboghene E Ubogu
Journal:  Cell Mol Neurobiol       Date:  2013-05-26       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.